Sandbox/0003: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Gerald Chi (talk | contribs)
CMEAdmin, Bureaucrats, bureaucrats, editnews, exportpages, interwiki, nocaptcha, nukepages, smwadministrator, Administrators, Widget editors
17,702 edits
Created page with "{| class="infobox" style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width: 250px;" cellpadding="0" cellspacing="0"; ! style="padding: 0 5px; font-size: 100..."
 
Gerald Chi (talk | contribs)
CMEAdmin, Bureaucrats, bureaucrats, editnews, exportpages, interwiki, nocaptcha, nukepages, smwadministrator, Administrators, Widget editors
17,702 edits
mNo edit summary
 
(5 intermediate revisions by the same user not shown)
Line 1: Line 1:
{| class="infobox" style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width: 250px;" cellpadding="0" cellspacing="0";
 
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF;" align=center | [[Metoprolol|{{fontcolor|#2B3B44|Metoprolol}}]]
{{cquote| quote here
|-
}}
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | [[Lopressor|{{fontcolor|#2B3B44|Lopressor (metoprolol tartrate) tablet}}]]
 
|-
 
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor indications and usage|Indications and Usage]]
 
|-
 
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor dosage and administration|Dosage and Administration]]
 
|-
 
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor dosage forms and strengths|Dosage Forms and Strengths]]
 
|-
{{Family tree/start}}
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor contraindications|Contraindications]]
{{Family tree|border=0|boxstyle=background: #FF0000; color: #F8F8FF;| | | | | | | | | | | | | A01 | | | | | | | | | | | | | |A01=
|-
<div style="text-align: left; height: 150px; width: 200px; padding: 5px;">
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor warnings and precautions|Warnings and Precautions]]
'''Symptoms & Signs''' <BR>
|-
----
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor adverse reactions|Adverse Reactions]]
❑ Altered mental status <BR>
|-
❑ Cyanosis <BR>
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor drug interactions|Drug Interactions]]
❑ Hypotension (MAP <60 mmHg)<BR>
|-
❑ Oliguria (<0.5 mL/kg/h) <BR>
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor use in specific populations|Use in Specific Populations]]
❑ Tachycardia <BR>
|-
❑ Tachypnea
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor overdosage|Overdosage]]
</div>}}
|-
{{Family tree|border=0|boxstyle=background: #FF0000; color: #F8F8FF;| | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor description|Description]]
{{Family tree|border=0|boxstyle=background: #FF0000; color: #F8F8FF;| | | | | | | | | | | | | B01 | | | | | | | | | | | | | |B01=
|-
<div style="text-align: center; height: 25px; width: 200px;">
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor clinical pharmacology|Clinical Pharmacology]]
'''Shock'''
|-
</div>}}
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor nonclinical toxicology|Nonclinical Toxicology]]
{{Family tree|border=0|boxstyle=background: #FF0000; color: #F8F8FF;| | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
|-
{{Family tree|border=0|boxstyle=background: #FF0000; color: #F8F8FF;| | | | | | | | | | | | | C01 | | | | | | | | | | | | | |C01=
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor clinical studies|Clinical Studies]]
<div style="text-align: left; height: 520px; width: 200px; padding: 5px;">
|-
'''Resuscitation''' <BR>
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor how supplied storage and handling|How Supplied/Storage and Handling]]
----
|-
❑ 0.5—1 L every 10—15 minutes<sup>†</sup> <BR>
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor patient counseling information|Patient Counseling Information]]
❑ ± Morphine 2—4 mg boluses <BR>
|-
❑ Ventilatory support <BR>
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor labels and packages|Labels and Packages]]
'''Labs & Imaging''' <BR>
|-
----
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor pill images|Pill Images]]
❑ CBC/DC/SMA-7/PT/PTT <BR>
|-
❑ Arterial blood gas <BR>
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | [[Toprol XL|{{fontcolor|#2B3B44|Toprol XL (metoprolol succinate) tablet, extended release}}]]
❑ Lactate <BR>
|-
❑ ECG <BR>
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL indications and usage|Indications and Usage]]
❑ CXR <BR>
|-
❑ Echocardiography <BR>
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL dosage and administration|Dosage and Administration]]
❑ CXR <BR>
|-
❑ Central venous catheter <BR>
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL dosage forms and strengths|Dosage Forms and Strengths]]
❑ Pulmonary artery catheter <BR>
|-
'''Immediate Goals''' <BR>
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL contraindications|Contraindications]]
----
|-
❑ MAP >60—65 mmHg <BR>
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL warnings and precautions|Warnings and Precautions]]
❑ CVP 8—12 mmHg <BR>
|-
❑ PCWP 12—15 mmHg <BR>
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL adverse reactions|Adverse Reactions]]
❑ CI >2.1 L/min/m<sup>2</sup> <BR>
|-
❑ Hemoglobin >7—9 g/dL <BR>
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL drug interactions|Drug Interactions]]
❑ SaO2 >90%—92% <BR>
|-
❑ MVO2 >60% <BR>
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL use in specific populations|Use in Specific Populations]]
❑ SCVO2 >70% <BR>
|-
❑ Lactate <2.2 mM/L <BR>
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL overdosage|Overdosage]]
❑ Urine output >0.5 mL/kg/h
|-
</div>}}
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL description|Description]]
{{Family tree|border=0|boxstyle=background: #FF0000; color: #F8F8FF;| | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
|-
{{Family tree|border=0|boxstyle=background: #FF0000; color: #F8F8FF;| | | | | | | | | | | | | D01 | | | | | | | | | | | | | |D01=
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL clinical pharmacology|Clinical Pharmacology]]
<div style="text-align: left; height: 130px; width: 200px;">
|-
</div>}}
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL nonclinical toxicology|Nonclinical Toxicology]]
{{Family tree/end}}
|-
 
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL clinical studies|Clinical Studies]]
<sup>†</sup> 100—200 mL boluses for cardiogenic shock
|-
 
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL how supplied storage and handling|How Supplied/Storage and Handling]]
 
|-
 
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL patient counseling information|Patient Counseling Information]]
 
|-
 
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL labels and packages|Labels and Packages]]
 
|-
----
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL pill images|Pill Images]]
 
|-
 
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | [[Metoprolol (patient information)|{{fontcolor|#2B3B44|Patient Information}}]]
 
|-
 
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | [http://clinicaltrials.gov/search/open/condition=Metoprolol {{fontcolor|#2B3B44|Clinical Trials}}]
<div style="width: 1px; height: 1px; background-color: #999999; position: fixed; top: 10px; left: 10px">
|-
 
|}
</div>

Latest revision as of 06:06, 30 March 2014

“ quote here ”




 
 
 
 
 
 
 
 
 
 
 
 

Symptoms & Signs

❑ Altered mental status
❑ Cyanosis
❑ Hypotension (MAP <60 mmHg)
❑ Oliguria (<0.5 mL/kg/h)
❑ Tachycardia
❑ Tachypnea

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Shock

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Resuscitation

❑ 0.5—1 L every 10—15 minutes†
❑ ± Morphine 2—4 mg boluses
❑ Ventilatory support
Labs & Imaging

❑ CBC/DC/SMA-7/PT/PTT
❑ Arterial blood gas
❑ Lactate
❑ ECG
❑ CXR
❑ Echocardiography
❑ CXR
❑ Central venous catheter
❑ Pulmonary artery catheter
Immediate Goals

❑ MAP >60—65 mmHg
❑ CVP 8—12 mmHg
❑ PCWP 12—15 mmHg
❑ CI >2.1 L/min/m2
❑ Hemoglobin >7—9 g/dL
❑ SaO2 >90%—92%
❑ MVO2 >60%
❑ SCVO2 >70%
❑ Lactate <2.2 mM/L
❑ Urine output >0.5 mL/kg/h

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

† 100—200 mL boluses for cardiogenic shock






Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox/0003&oldid=961056"